Barely Significant
← all excerpts

SF3B1 mutations constitute a novel therapeutic target in breast cancer.

J Pathol · 2015 · PMC4643177 · PMID 25424858

Europe PMCDOI
1
hedged sentence
0.9434
closest p · 18.9× alpha
0.9434
boldest claim

The sentences

showed a trendp = 0.9434not close (p > 0.1)
Although not significant, mutations in LUC7L2 and SAP130 showed a trend towards co-occurrence (odds ratio = 2.883, p = 0.9434, Fisher's exact test).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.